These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 38843513

  • 1. Feasibility of Web-Based Single-Session Empowered Relief in Patients With Chronic Pain Taking Methadone or Buprenorphine: Protocol for a Single-Arm Trial.
    Klein MR, Darnall BD, You DS.
    JMIR Res Protoc; 2024 Jun 06; 13():e53784. PubMed ID: 38843513
    [Abstract] [Full Text] [Related]

  • 2. Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal.
    D'Onofrio G, Herring AA, Perrone J, Hawk K, Samuels EA, Cowan E, Anderson E, McCormack R, Huntley K, Owens P, Martel S, Schactman M, Lofwall MR, Walsh SL, Dziura J, Fiellin DA.
    JAMA Netw Open; 2024 Jul 01; 7(7):e2420702. PubMed ID: 38976265
    [Abstract] [Full Text] [Related]

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment.
    MacLean RR, Ankawi B, Driscoll MA, Gordon MA, Frankforter TL, Nich C, Szollosy SK, Loya JM, Brito L, Ribeiro MIP, Edmond SN, Becker WC, Martino S, Sofuoglu M, Heapy AA.
    JMIR Res Protoc; 2024 Mar 20; 13():e54342. PubMed ID: 38506917
    [Abstract] [Full Text] [Related]

  • 5. Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial.
    Ellerbroek H, van den Heuvel SAS, Dahan A, Timmerman H, Kramers C, Schellekens AFA.
    Addict Sci Clin Pract; 2022 Sep 04; 17(1):47. PubMed ID: 36057608
    [Abstract] [Full Text] [Related]

  • 6. Mental Health Distress Is Associated With Higher Pain Interference in Patients With Opioid Use Disorder Stabilized on Buprenorphine or Methadone.
    Leyde S, Price CJ, Colgan DD, Pike KC, Tsui JI, Merrill JO.
    Subst Use Addctn J; 2024 Jul 04; 45(3):423-433. PubMed ID: 38327009
    [Abstract] [Full Text] [Related]

  • 7. Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR) as an adjunct to medications for opioid use disorder: a Phase 1 trial.
    Garland EL, Recasens M, Taple BJ, Donaldson GW, Weisberg RB.
    Ann Med; 2024 Dec 04; 56(1):2392870. PubMed ID: 39172534
    [Abstract] [Full Text] [Related]

  • 8. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M, Flannery M, Badolato R, Vittitow A, McDonald RD, Tofighi B, Garment AR, Giftos J, Lee JD.
    Addict Sci Clin Pract; 2019 Oct 01; 14(1):37. PubMed ID: 31570100
    [Abstract] [Full Text] [Related]

  • 9. Post-operative pain control in patients on buprenorphine or methadone for opioid use disorder.
    Quaye A, Tsafnat T, Richard JM, Stoddard H, Gagnon DJ.
    J Opioid Manag; 2024 Oct 01; 20(3):233-241. PubMed ID: 39017615
    [Abstract] [Full Text] [Related]

  • 10. Integrating cognitive bias modification for pain and opioid cues into medication for opioid use disorder clinical care: Feasibility, acceptability, and preliminary results.
    MacLean RR, Heapy AA, Waters AJ, Wolkowicz N, Szollosy SK, Meyerovich J, Sofuoglu M.
    Drug Alcohol Depend; 2023 May 01; 246():109857. PubMed ID: 37004461
    [Abstract] [Full Text] [Related]

  • 11. Comparison of a Single-Session Pain Management Skills Intervention With a Single-Session Health Education Intervention and 8 Sessions of Cognitive Behavioral Therapy in Adults With Chronic Low Back Pain: A Randomized Clinical Trial.
    Darnall BD, Roy A, Chen AL, Ziadni MS, Keane RT, You DS, Slater K, Poupore-King H, Mackey I, Kao MC, Cook KF, Lorig K, Zhang D, Hong J, Tian L, Mackey SC.
    JAMA Netw Open; 2021 Aug 02; 4(8):e2113401. PubMed ID: 34398206
    [Abstract] [Full Text] [Related]

  • 12. Perceived social support in patients with chronic pain with and without opioid use disorder and role of medication for opioid use disorder.
    Benville JR, Compton P, Giordano NA, Cheatle MD.
    Drug Alcohol Depend; 2021 Apr 01; 221():108619. PubMed ID: 33667781
    [Abstract] [Full Text] [Related]

  • 13. Protocol for a randomised trial of a self-directed digital pain management intervention (Empowered Relief) tailored to adults with chronic pain and prescription opioid misuse/disorder: the MOBILE Relief study.
    Edwards KA, Palenski P, Perez L, You DS, Ziadni MS, Jung C, Adair E, Tian L, Mackey SC, Darnall BD.
    BMJ Open; 2024 Aug 09; 14(8):e086889. PubMed ID: 39122392
    [Abstract] [Full Text] [Related]

  • 14. Variation in Opioid Agonist Dosing in Clinical Trials by Race and Ethnicity.
    Ross RK, Inose S, Shulman M, Nunes EV, Zalla LC, Burlew AK, Rudolph KE.
    JAMA Netw Open; 2024 Oct 01; 7(10):e2436612. PubMed ID: 39365581
    [Abstract] [Full Text] [Related]

  • 15. Rationale and design of a multisite randomized clinical trial examining an integrated behavioral treatment for veterans with co-occurring chronic pain and opioid use disorder: The pain and opioids integrated treatment in veterans (POSITIVE) trial.
    Vowles KE, Witkiewitz K, Clarke E, Schmidt Z, Borsari B, Edwards KE, Korecki JR, Moniz-Lewis DI, Bondzie JA, Mullins C, Thoreson CI, Delacruz J, Wilkins CH, Nelson S, Delventura J, Henderson R, Katz A, Hua W, Watson E, Baxley C, Canlas BR, Pendleton T, Herbst E, Batki S.
    Contemp Clin Trials; 2023 Mar 01; 126():107096. PubMed ID: 36693589
    [Abstract] [Full Text] [Related]

  • 16. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.
    Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM.
    JAMA Netw Open; 2020 Feb 05; 3(2):e1920622. PubMed ID: 32022884
    [Abstract] [Full Text] [Related]

  • 17. Opioid tapering in patients with prescription opioid use disorder: A retrospective study.
    Zhou K, Jia P, Bhargava S, Zhang Y, Reza T, Peng YB, Wang GG.
    Scand J Pain; 2017 Oct 05; 17():167-173. PubMed ID: 28988103
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a Single-Session "Empowered Relief" Zoom-Delivered Group Intervention for Chronic Pain: Randomized Controlled Trial Conducted During the COVID-19 Pandemic.
    Ziadni MS, Gonzalez-Castro L, Anderson S, Krishnamurthy P, Darnall BD.
    J Med Internet Res; 2021 Sep 10; 23(9):e29672. PubMed ID: 34505832
    [Abstract] [Full Text] [Related]

  • 19. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.
    Scott TM, Arnsten J, Olsen JP, Arias F, Cunningham CO, Rivera Mindt M.
    Addict Sci Clin Pract; 2021 Oct 24; 16(1):64. PubMed ID: 34689841
    [Abstract] [Full Text] [Related]

  • 20. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R, Ingram J, Rees A, Neale J, Beattie A, Telfer M.
    Subst Abuse Treat Prev Policy; 2014 Nov 18; 9():44. PubMed ID: 25407020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.